Rare Diseases and Orphan Drugs:

Rare diseases affect a small percentage of the population but collectively impact millions worldwide. Orphan drugs, developed specifically for these conditions, face unique challenges due to the limited market size. However, incentives such as the Orphan Drug Act and global collaborations have significantly boosted research and development. Despite high development costs, orphan drugs represent a lifeline for patients with otherwise untreatable diseases. The pathway from discovery to market is complex, involving rigorous regulatory scrutiny, innovative trial designs, and patient advocacy support to ensure that these drugs are both safe and accessible.

 

    Related Conference of Rare Diseases and Orphan Drugs:

    May 18-19, 2026

    15th World Congress on Rare Diseases and Orphan Drugs

    Prague, Czech Republic
    June 29-30, 2026

    7th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 25-26, 2026

    18th Global Conference on Nephrology and Infectious Diseases

    Amsterdam, Netherlands

    Rare Diseases and Orphan Drugs: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in